BRPI0507352A - reações de acoplamento úteis na preparação de derivados de (1h-tetrazol-5-il)-bifenila - Google Patents

reações de acoplamento úteis na preparação de derivados de (1h-tetrazol-5-il)-bifenila

Info

Publication number
BRPI0507352A
BRPI0507352A BRPI0507352-9A BRPI0507352A BRPI0507352A BR PI0507352 A BRPI0507352 A BR PI0507352A BR PI0507352 A BRPI0507352 A BR PI0507352A BR PI0507352 A BRPI0507352 A BR PI0507352A
Authority
BR
Brazil
Prior art keywords
tetrazol
preparation
coupling reactions
biphenyl derivatives
reactions useful
Prior art date
Application number
BRPI0507352-9A
Other languages
English (en)
Inventor
Christoph Krell
Hans Hirt
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0507352A publication Critical patent/BRPI0507352A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

'REAçõES DE COPLAMENTO úTEIS NA PREPARAçãO DE DERIVADOS DE (1H-TETRAZOL-5-IL)-BIFENILA". A presente invenção refere-se a um processo para a fabricação de intermediários que podem ser usados para a fabricação de ARbs (também denominados antagonistas de receptor de angiotensina II ou antagonistas de receptor de AT1), compreendendo como uma característica estrutural comum, um anel (1H-tetrazol-5-il)- bifenila.
BRPI0507352-9A 2004-02-02 2005-02-01 reações de acoplamento úteis na preparação de derivados de (1h-tetrazol-5-il)-bifenila BRPI0507352A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0402262.0A GB0402262D0 (en) 2004-02-02 2004-02-02 Process for the manufacture of organic compounds
PCT/EP2005/000978 WO2005075462A1 (en) 2004-02-02 2005-02-01 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives

Publications (1)

Publication Number Publication Date
BRPI0507352A true BRPI0507352A (pt) 2007-07-03

Family

ID=31985494

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507352-9A BRPI0507352A (pt) 2004-02-02 2005-02-01 reações de acoplamento úteis na preparação de derivados de (1h-tetrazol-5-il)-bifenila

Country Status (19)

Country Link
US (2) US7700784B2 (pt)
EP (2) EP1716140A1 (pt)
JP (1) JP2007519684A (pt)
KR (1) KR20060128993A (pt)
CN (1) CN100528868C (pt)
AU (1) AU2005211500B2 (pt)
BR (1) BRPI0507352A (pt)
CA (1) CA2553246A1 (pt)
CO (1) CO5700717A2 (pt)
EC (1) ECSP066727A (pt)
GB (1) GB0402262D0 (pt)
IL (2) IL176904A0 (pt)
MA (1) MA28427B1 (pt)
NO (1) NO20063920L (pt)
NZ (1) NZ548690A (pt)
RU (2) RU2426728C2 (pt)
TN (1) TNSN06238A1 (pt)
WO (1) WO2005075462A1 (pt)
ZA (1) ZA200605462B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
JP5023720B2 (ja) * 2006-08-04 2012-09-12 東ソー株式会社 ハロゲン化ビフェニル類の製造方法
FI3067043T3 (fi) * 2007-11-06 2023-03-18 Novartis Ag Angiotensiinireseptoriantagonistin/-salpaajan (arb) ja neutraalin endopeptidaasin (nep) estäjän superrakenteisiin perustuvia farmaseuttisia koostumuksia
PE20091364A1 (es) 2008-01-17 2009-10-13 Novartis Ag Proceso para la preparacion de inhibidores de nep
JP5203144B2 (ja) * 2008-11-07 2013-06-05 東ソー株式会社 スチレン類の製造方法
JP5261140B2 (ja) * 2008-11-07 2013-08-14 東ソー株式会社 ビニル芳香族化合物の製造方法
KR101476937B1 (ko) 2010-08-23 2014-12-24 노파르티스 아게 Ｎｅｐ 억제제의 제조를 위한 중간체의 제조 방법
PL2610248T3 (pl) * 2010-08-27 2016-12-30 Sposób wytwarzania podstawionych fenylem pochodnych heterocyklicznych metodą sprzęgania z użyciem związku palladu
CN103467341B (zh) * 2013-08-29 2015-02-25 河南师范大学 一种沙坦联苯的制备方法
CN104987327A (zh) * 2015-07-13 2015-10-21 朱绍清 一种四唑类衍生物的催化合成方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4874867A (en) * 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DE69034103T2 (de) 1989-06-14 2004-07-15 Smithkline Beecham Corp. Imidazoalkensäure
PH30484A (en) 1990-02-19 1997-05-28 Ciba Geigy Acy compounds pharmaceutical composition containing said compound and method of use thereof
GB9005354D0 (en) * 1990-03-09 1990-05-02 Glaxo Group Ltd Chemical compounds
NZ237476A (en) 1990-03-20 1994-01-26 Sanofi Sa N-substituted heterocyclic compounds and pharmaceutical compositions.
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
CA2229000C (en) 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
TW226375B (pt) 1991-10-24 1994-07-11 American Home Prod
US5206374A (en) * 1991-11-18 1993-04-27 E. I. Du Pont De Nemours And Company Process for preparing tetrazolylphenylboronic acid intermediates
US5310928A (en) * 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
EP0550313A1 (fr) * 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
FR2688503B1 (fr) 1992-03-16 1994-05-06 Synthelabo Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1'-biphenyle].
US5468867A (en) * 1994-05-27 1995-11-21 Syntex (U.S.A.) Inc. Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid
JP4108744B2 (ja) 1994-10-27 2008-06-25 ノバルティス アクチェンゲゼルシャフト テトラゾールの製法
JP3763869B2 (ja) * 1994-12-26 2006-04-05 東ソー・ファインケム株式会社 ビフェニル化合物の製造方法
US5922898A (en) * 1997-04-08 1999-07-13 Catalytica Pharmaceuticals, Inc. Process for preparing biaryl compounds
DE10057679A1 (de) * 2000-11-21 2002-05-29 Forschungszentrum Juelich Gmbh Brennstoffzellenstapel mit Kreislaufführung
BR0313000A (pt) * 2002-07-19 2005-07-12 Memory Pharm Corp Compostos, composição farmacêutica e método para efetuar a inibição da enzima pde4, realçar a cognição e/ou tratar a psicose em um paciente
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
CA2640585A1 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol{4,4}-non-ene-4-one
PT2272868E (pt) 2003-06-05 2015-07-07 Genentech Inc Terapêutica de combinação para distúrbios de células b

Also Published As

Publication number Publication date
CN1914197A (zh) 2007-02-14
CN100528868C (zh) 2009-08-19
US7700784B2 (en) 2010-04-20
ZA200605462B (en) 2009-06-24
CO5700717A2 (es) 2006-11-30
EP2246348A1 (en) 2010-11-03
CA2553246A1 (en) 2005-08-18
GB0402262D0 (en) 2004-03-10
EP1716140A1 (en) 2006-11-02
NO20063920L (no) 2006-10-30
JP2007519684A (ja) 2007-07-19
KR20060128993A (ko) 2006-12-14
NZ548690A (en) 2009-08-28
IL176904A0 (en) 2006-12-10
US20100152458A1 (en) 2010-06-17
RU2010136996A (ru) 2012-03-20
TNSN06238A1 (en) 2007-12-03
US20070129413A1 (en) 2007-06-07
AU2005211500B2 (en) 2009-04-02
IL208409A0 (en) 2011-08-01
RU2426728C2 (ru) 2011-08-20
AU2005211500A1 (en) 2005-08-18
RU2006131460A (ru) 2008-03-10
MA28427B1 (fr) 2007-02-01
ECSP066727A (es) 2006-10-31
WO2005075462A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
BRPI0507352A (pt) reações de acoplamento úteis na preparação de derivados de (1h-tetrazol-5-il)-bifenila
HN2005000795A (es) Pirimidinas como antagonistas del receptor de prostaglandina d2
MA33198B1 (fr) Anticorps anti-her di-spécifiques
BRPI0508622A (pt) compostos de bifenil úteis como antagonistas do receptor muscarìnico
MX2009005363A (es) Pirimidinas y su uso como antagonistas del receptor cxcr2.
TW200740814A (en) Compounds
BRPI0712819B8 (pt) composto para liberação controlada de opióides fenólicos, processo para a preparação do referido composto e composição farmacêutica
TW200714587A (en) Biphenyl compounds useful as muscarinic receptor antagonists
TW200745149A (en) Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
BRPI0910182A2 (pt) composto de fórmula (i), composição farmacêutica, método de tratamento de um distúrbio e uso de um composto"
CO6390082A2 (es) Compuestos organicos
WO2007038669A3 (en) Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
MX2009004780A (es) Derivados de quiniclidina de acido (hetero) arilcicloheptano carboxilico como antagonistas del receptor muscarinico.
BRPI0607309A2 (pt) processos para a preparação de fenilpirazol uréias substituìdas
HN2008001530A (es) Compuestos de amino pirimidina 2,6- sustituidos -4-monosustituidos como antagonistas del receptor de prostaglandina d2
ECSP067091A (es) Procesos para preparacion de antagonistas de receptor de hormona que libera gonadotropina
CY1108880T1 (el) Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα
WO2008045371A3 (en) N-substituted-azacyclylamines as histamine-3 antagonists
EA200701648A1 (ru) Замещённые пирролы и имидазолы, содержащие их композиции, способ получения и применение
UY31243A1 (es) Compuestos de 2-aza-biciclo[2.2.2]octano y usos para los mismos
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
BRPI0606639A2 (pt) novo processo para a preparação de indóis substituìdos
BRPI0918517B8 (pt) composto, composição farmacêutica, e, uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE, CONFORME ART. 10 DA RES. 124/06.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.